Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ji Fan Hu

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Theranostics|December 8, 2025
Mitochondria-specific targeting of noncanonical <i>EGR1</i> ntmRNA-coordinated mitophagy receptor BNIP3 homodimerization disrupts mitochondrial metabolism and suppresses hepatocellular carcinoma growth <i>in vitro</i> and <i>in vivo</i>Yan Li, Lei Zhou, Mengmeng Liu, et al.
Molecular Cancer|November 23, 2012
Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting systemZhen-Lin Nie, Yu-Qin Pan, Bang-Shun He, et al.
Genome Biology|December 13, 2018
A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1Naifei Chen, Gang Zhao, Xu Yan, et al.
The Journal of Biological Chemistry|February 1, 2002
An imprinted PEG1/MEST antisense expressed predominantly in human testis and in mature spermatozoaTao Li, Thanh H Vu, Kok-Onn Lee, et al.
Nucleic Acids Research|February 15, 2020
Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylationLin Jia, Yichen Wang, Cong Wang, et al.
American Journal of Cancer Research|September 10, 2019
Profiling the epigenetic interplay of lncRNA RUNXOR and oncogenic RUNX1 in breast cancer cells by gene in situ cis-activationYuanyuan Nie, Lei Zhou, Hong Wang, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis CompetitionLingling Pian, Xue Wen, Lihua Kang, et al.
Nature Communications|July 14, 2017
Manipulation of nuclear architecture through CRISPR-mediated chromosomal loopingStefanie L Morgan, Natasha C Mariano, Abel Bermudez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2022
LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotencyYanbo Zhu, Zi Yan, Changhao Fu, et al.
Cells|October 14, 2022
Intrachromosomal Looping and Histone K27 Methylation Coordinately Regulates the lncRNA <i>H19</i>-Fetal Mitogen <i>IGF2</i> Imprinting Cluster in the Decidual Microenvironment of Early PregnancyXue Wen, Qi Zhang, Lei Zhou, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Theranostics|December 8, 2025
Mitochondria-specific targeting of noncanonical <i>EGR1</i> ntmRNA-coordinated mitophagy receptor BNIP3 homodimerization disrupts mitochondrial metabolism and suppresses hepatocellular carcinoma growth <i>in vitro</i> and <i>in vivo</i>Yan Li, Lei Zhou, Mengmeng Liu, et al.
Molecular Cancer|November 23, 2012
Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting systemZhen-Lin Nie, Yu-Qin Pan, Bang-Shun He, et al.
Genome Biology|December 13, 2018
A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1Naifei Chen, Gang Zhao, Xu Yan, et al.
The Journal of Biological Chemistry|February 1, 2002
An imprinted PEG1/MEST antisense expressed predominantly in human testis and in mature spermatozoaTao Li, Thanh H Vu, Kok-Onn Lee, et al.
Nucleic Acids Research|February 15, 2020
Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylationLin Jia, Yichen Wang, Cong Wang, et al.
American Journal of Cancer Research|September 10, 2019
Profiling the epigenetic interplay of lncRNA RUNXOR and oncogenic RUNX1 in breast cancer cells by gene in situ cis-activationYuanyuan Nie, Lei Zhou, Hong Wang, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis CompetitionLingling Pian, Xue Wen, Lihua Kang, et al.
Nature Communications|July 14, 2017
Manipulation of nuclear architecture through CRISPR-mediated chromosomal loopingStefanie L Morgan, Natasha C Mariano, Abel Bermudez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2022
LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotencyYanbo Zhu, Zi Yan, Changhao Fu, et al.
Cells|October 14, 2022
Intrachromosomal Looping and Histone K27 Methylation Coordinately Regulates the lncRNA <i>H19</i>-Fetal Mitogen <i>IGF2</i> Imprinting Cluster in the Decidual Microenvironment of Early PregnancyXue Wen, Qi Zhang, Lei Zhou, et al.
Pageof 10